Results 121 to 130 of about 74,894 (355)

Оценка качества жизни при различных сердечно-сосудистых заболеваниях

Качественная клиническая практика, 2018
Различные заболевания влияют не только на физическое состояние человека, но и на психологию его поведения, эмоциональные реакции, а также изменяют его место и роль в социальной жизни. Чаще всего в поле зрения врача оказываются физикальные, лабораторные и

doaj  

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson   +4 more
wiley   +1 more source

Artificial Intelligence for Regulatory Evidence: A Systematic Document Analysis of European Medicines Agency Regulatory Advice and Public Reports

Clinical Pharmacology &Therapeutics, EarlyView.
Artificial intelligence (AI) is receiving increasing attention across the entire lifecycle of medicines, from early development to postauthorization use. While various AI tools have been developed in commercial and academic settings, the extent of their use in regulatory contexts within the European Union remains unknown.
Lucina‐May Nollen, Gerard J.P. van Westen, Gabriel Westman, Anna M.G. Pasmooij   +3 more
wiley   +1 more source

The Use of QALYs in Clinical and Patient Decision-Making: Issues and Prospects

Качественная клиническая практика, 2018
.
Paul Kind, Jennifer Elston Lafata, Karl Matuszewski, Dennis Raisch, I. A. Vilum, A. S. Kolbin   +5 more
doaj  

Green Human Resource Management (GHRM) and Environment Social Governance (ESG): A Systematic Literature Review

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This paper presents a systematic literature review exploring the intersection of Green Human Resource Management (GHRM) and Environmental, Social, and Governance (ESG) criteria. The study synthesizes current research, identifies prevailing trends, and highlights gaps within this emerging field.
Zile Huma, Emma Garcia Meca, Jennifer Martínez‐Ferrero, Nazim Hussain   +3 more
wiley   +1 more source

Pharmacoeconomic analysis of use the oral hypoglycemic agents in patients with type 2 diabetes mellitus according to a real clinical practice

Качественная клиническая практика, 2018
We aimed to conduct cost-utility analysis of two different regimens of the oral hypoglycemic therapy in 2 type diabetes mellitus (DM2). Methods. In the whole, 229 patients with DM2, receiving vildagliptin add-on to metformin (group 1) or sulphonylureas ...
T. I. Ionova, T. P. Nikitina, A. Y. Rodionov, K. A. Kurbatova   +3 more
doaj  

How 1st‐Tier Suppliers Respond to Green Public Procurement Policies: An Empirical Analysis

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This article analyses how 1st‐tier suppliers to public organisations respond operationally to Green Public Procurement (GPP) policies. Through a multiple case study of 12 Italian firms operating in different sectors, we develop a classification of suppliers' responses, identifying two interrelated macro‐types: internal operations realignment ...
Antonio Cavallin Toscani, Andrea Vinelli
wiley   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Patient Specific Pre-Treatment QA Verification Using an EPID Approach [PDF]

, 2013
Luis Alberto Vazquez Quino, Xiaoming Chen, Mathew J. Fitzpatrick, Chengyu Shi, S Stathakis, Alonso N. Gutiérrez, C Esquivel, Panayiotis Mavroidis, Hassan Alkhatib, Niko Papanikolaou   +9 more
openalex   +1 more source

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source